1. Home
  2. ANVS vs YSXT Comparison

ANVS vs YSXT Comparison

Compare ANVS & YSXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • YSXT
  • Stock Information
  • Founded
  • ANVS 2008
  • YSXT 2011
  • Country
  • ANVS United States
  • YSXT China
  • Employees
  • ANVS N/A
  • YSXT N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • YSXT Automotive Aftermarket
  • Sector
  • ANVS Health Care
  • YSXT Consumer Discretionary
  • Exchange
  • ANVS Nasdaq
  • YSXT Nasdaq
  • Market Cap
  • ANVS 31.2M
  • YSXT 87.9M
  • IPO Year
  • ANVS 2020
  • YSXT 2024
  • Fundamental
  • Price
  • ANVS $1.62
  • YSXT $2.65
  • Analyst Decision
  • ANVS Strong Buy
  • YSXT
  • Analyst Count
  • ANVS 5
  • YSXT 0
  • Target Price
  • ANVS $37.00
  • YSXT N/A
  • AVG Volume (30 Days)
  • ANVS 447.8K
  • YSXT 53.6K
  • Earning Date
  • ANVS 03-31-2025
  • YSXT 02-24-2025
  • Dividend Yield
  • ANVS N/A
  • YSXT N/A
  • EPS Growth
  • ANVS N/A
  • YSXT N/A
  • EPS
  • ANVS N/A
  • YSXT 0.18
  • Revenue
  • ANVS N/A
  • YSXT $66,143,276.00
  • Revenue This Year
  • ANVS N/A
  • YSXT N/A
  • Revenue Next Year
  • ANVS N/A
  • YSXT N/A
  • P/E Ratio
  • ANVS N/A
  • YSXT $15.10
  • Revenue Growth
  • ANVS N/A
  • YSXT 21.23
  • 52 Week Low
  • ANVS $1.53
  • YSXT $2.06
  • 52 Week High
  • ANVS $20.00
  • YSXT $6.27
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 19.82
  • YSXT N/A
  • Support Level
  • ANVS $1.57
  • YSXT N/A
  • Resistance Level
  • ANVS $1.77
  • YSXT N/A
  • Average True Range (ATR)
  • ANVS 0.18
  • YSXT 0.00
  • MACD
  • ANVS 0.07
  • YSXT 0.00
  • Stochastic Oscillator
  • ANVS 8.38
  • YSXT 0.00

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares

YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.

Share on Social Networks: